Pulmonary fibrosis secondary to COVID-19: a narrative review

SE Tanni, AT Fabro, A de Albuquerque… - Expert review of …, 2021 - Taylor & Francis
ABSTRACT Introduction: Coronavirus disease 2019 (COVID-19) is still increasing
worldwide, and as a result, the number of patients with pulmonary fibrosis secondary to …

Postmortem findings associated with SARS-CoV-2: systematic review and meta-analysis

S Satturwar, M Fowkes, C Farver… - The American journal …, 2021 - journals.lww.com
Abstract Coronavirus Disease 2019 (COVID-19), caused by the novel Severe Acute
Respiratory Syndrome–associated Coronavirus 2 (SARS-CoV-2), has become a global …

Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination

C Schwab, LM Domke, L Hartmann… - Clinical Research in …, 2023 - Springer
Cases of myocarditis, diagnosed clinically by laboratory tests and imaging have been
described in the context of mRNA-based anti-SARS-CoV-2 vaccination. Autopsy-based …

Lung function and radiological findings 1 year after COVID-19: a prospective follow-up

J Tarraso, B Safont, JA Carbonell-Asins… - Respiratory …, 2022 - Springer
Background The coronavirus disease (COVID-19) pandemic has already affected more than
400 million people, with increasing numbers of survivors. These data indicate that a myriad …

Vitamin D and lung outcomes in elderly COVID-19 patients

A Sulli, E Gotelli, A Casabella, S Paolino, C Pizzorni… - Nutrients, 2021 - mdpi.com
Background and aim: Vitamin D deficiency is frequently reported in patients with SARS-CoV-
2 infection. The aim of this study was to correlate the 25OH-Vitamin D serum concentrations …

The pulmonary pathology of COVID-19

H Bösmüller, M Matter, F Fend, A Tzankov - Virchows Archiv, 2021 - Springer
The lung is the main affected organ in severe coronavirus disease 2019 (COVID-19) caused
by the novel coronavirus SARS-CoV-2, and lung damage is the leading cause of death in …

Bacterial superinfections among persons with coronavirus disease 2019: a comprehensive review of data from postmortem studies

CJ Clancy, IS Schwartz, B Kula… - Open Forum Infectious …, 2021 - academic.oup.com
Background Limited clinical data suggest a~ 16% prevalence of bacterial superinfections
among critically ill patients with coronavirus disease 2019 (COVID-19). Methods We …

Invasive mould disease in fatal COVID-19: a systematic review of autopsies

BE Kula, CJ Clancy, MH Nguyen, IS Schwartz - The Lancet Microbe, 2021 - thelancet.com
Invasive mould disease (IMD) might affect up to a third of critically ill patients with COVID-19.
COVID-19-associated pulmonary aspergillosis (CAPA) is typically diagnosed on the basis of …

COVID-19 mortality as a fingerprint of biological age

MC Polidori, H Sies, L Ferrucci, T Benzing - Ageing research reviews, 2021 - Elsevier
Abstract Corona virus disease 2019 (COVID-19) is a global emergency able to overwhelm
the healthcare capacities worldwide and to affect the older generation especially. When …

Pulmonary pathology of COVID-19: a review of autopsy studies

AC Borczuk - Current opinion in pulmonary medicine, 2021 - journals.lww.com
The heterogeneity of fatal cases-persistence of viral infection in lung, clearance of virus but
severe lung injury, thrombosis, and exaggerated immune response–suggest that antiviral …